CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Net income, 2025
- $100M
- YoY, 2025
- −29.4%
- 5-year CAGR
- −1.2%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $100M | −29.4% |
| 2024 | $141M | +33.0% |
| 2023 | $106M | +4.7% |
| 2022 | $101M | −9.9% |
| 2021 | $113M | +6.1% |
| 2020 | $106M | +12.6% |
| 2019 | $94M | +24.9% |
| 2018 | $75M | −41.6% |
| 2017 | $129M | +1,486.3% |
| 2016 | $8.1M | — |
| 2015 | −$6.4M | — |
| 2014 | −$31M | — |
| 2013 | −$46M | — |
| 2012 | −$38M | — |
| 2011 | −$32M | — |
| 2010 | −$26M | — |
| 2009 | −$20M | — |
| 2008 | −$20M | — |
| 2007 | −$12M | — |
| 2006 | −$25M | — |
| 2005 | −$20M | — |
| 2004 | −$16M | — |
| 2003 | −$9.8M | — |
| 2002 | −$19M | — |
| 2001 | −$7.5M | — |
| 2000 | −$1.8M | — |